Compare RDY & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | ONON |
|---|---|---|
| Founded | 1984 | 2010 |
| Country | India | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 9.4B |
| IPO Year | 2001 | 2021 |
| Metric | RDY | ONON |
|---|---|---|
| Price | $12.50 | $35.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 31 |
| Target Price | $13.22 | ★ $43.38 |
| AVG Volume (30 Days) | 2.9M | ★ 11.3M |
| Earning Date | 10-23-2026 | 11-11-2026 |
| Dividend Yield | ★ 0.53% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.75 | $16.59 |
| Revenue Next Year | $11.72 | $18.95 |
| P/E Ratio | ★ $18.67 | $56.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.36 | $26.37 |
| 52 Week High | $15.67 | $51.08 |
| Indicator | RDY | ONON |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 76.59 |
| Support Level | $12.09 | $35.02 |
| Resistance Level | $12.48 | $38.73 |
| Average True Range (ATR) | 0.22 | 1.08 |
| MACD | -0.00 | 0.75 |
| Stochastic Oscillator | 48.00 | 99.91 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Founded in Switzerland in 2010, sportswear firm On Holding generates more than 90% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of 2025 sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.